➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKesson
Dow
Merck
Colorcon
Express Scripts
Baxter

Last Updated: May 17, 2021

DrugPatentWatch Database Preview

Litigation Details for DEXCEL PHARMA TECHNOLOGIES LTD. v. SUN PHARMA GLOBAL FZE (D.N.J. 2015)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Small Molecule Drugs cited in DEXCEL PHARMA TECHNOLOGIES LTD. v. SUN PHARMA GLOBAL FZE
The small molecule drug covered by the patent cited in this case is   Get Started Free .

Details for DEXCEL PHARMA TECHNOLOGIES LTD. v. SUN PHARMA GLOBAL FZE (D.N.J. 2015)

Date Filed Document No. Description Snippet Link To Document
2015-11-11 1 United States Patent Nos. 9,023,391 (“the ’391 patent”) and 7,255,878 (“the ’878 patent”) (collectively… 1. This is an action for patent infringement under the patent laws of the United States, 35 U.S.C… The Patents-in-suit 9. On May 5, 2015, the United States Patent and Trademark …issued the ’391 patent, entitled “Stable Benzimidazole Formulation.” A copy of the ’391 patent is attached…issued the ’878 patent, entitled “Stable Benzimidazole Formulation.” A copy of the ’878 patent is attached External link to document
2017-03-13 88 regarding patent claims in Plaintiffs’ U.S. Patent Nos. 7,255,878 (“the ’878 patent”) and 9,023,391 (“the…regarding the request for a patent claim construction pursuant to Local Patent Rule 4.5(a). …the ’391 patent”) (collectively, “the patents-in-suit”). After carefully considering the parties’ written…) infringement of the ’391 patent and (II) infringement of the ’878 patent. (Compl. 1 Markman …claim phrases: three in the ‘878 patent and two in the ‘391 patent. Defendants offer proposed constructions External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Johnson and Johnson
Moodys
AstraZeneca
Mallinckrodt
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.